Adial Pharmaceuticals Inc. (ADIL)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2025, 2:25pm based on SEC 13F filings Last update: November 14, 2025, 2:25pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Citadel Investment Group Ken Griffin	143,791	$50,830		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Schuyler Director	$2.74	700	$1,918.00	700	2023-09-29	Filing
Newman Director	$2.71	10,000	$27,100.00	34,644	2021-12-30	Filing
Newman Director	$2.72	5,000	$13,600.00	50,221	2021-12-30	Filing
Newman Director	$2.66	10,000	$26,600.00	20,000	2021-12-30	Filing
Stilley Large Shareholder, Officer, Director	$2.75	10,600	$29,178.62	937,646	2021-11-30	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Johnson Officer	$0.00	200,000	$0.00	148,246	2021-10-04	Filing
Johnson Officer	$2.50	150,000	$375,000.00	548,336	2021-04-06	Filing
Johnson Officer	$1.21	350,000	$423,500.00	1,055	2020-08-20	Filing
Johnson Large Shareholder, Officer	$1.00	150,000	$150,000.00	698,336	2019-12-12	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Geode Capital Management, Llc	164,127	$58,018	0%
2.	Vanguard Group Inc	156,024	$55,232	0%
3.	Manchester Capital Management Llc	48,097	$17,003	0%
4.	Blackrock, Inc.	27,770	$9,817	0%
5.	Ubs Group Ag	18,758	$6,622	0%